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Background: The clinical features of mitochondrial disease are complex and highly variable, leading to challenges
in establishing a specific diagnosis. Despite being one of the most commonly occurring inherited genetic diseases
with an incidence of 1/5000, ~90% of these complex patients remain without a DNA-based diagnosis. We report
our efforts to identify the pathogenetic cause for a patient with typical features of mitochondrial disease including
infantile cataracts, CPEO, ptosis, progressive distal muscle weakness, and ataxia who carried a diagnosis of
mitochondrial disease for over a decade.
Methods: Whole exome sequencing and bioinformatic analysis of these data were conducted on the proband.
Results: Exome sequencing studies showed a homozygous splice site mutation in SETX, which is known to cause
Spinocerebellar Ataxia, Autosomal Recessive 1 (SCAR1). Additionally a missense mutation was identified in a highly
conserved position of the OCRL gene, which causes Lowe Syndrome and Dent Disease 2.
Conclusions: This patient’s complex phenotype reflects a complex genetic etiology in which no single gene
explained the complete clinical presentation. These genetic studies reveal that this patient does not have
mitochondrial disease but rather a genocopy caused by more than one mutant locus. This study demonstrates the
benefit of exome sequencing in providing molecular diagnosis to individuals with complex clinical presentations.
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The clinical presentation of mitochondrial disease is highly
complex and variable, resulting in diagnostic challenges.
Numerous manifestations include subacute necrotizing
encephalomyelopathy (Leigh disease), cardiomyopathy,
skeletal myopathy, anemia, intestinal pseudo-obstruction,
liver failure, sensorineural hearing loss, diabetes and other
endocrinopathies, renal tubulopathy, and growth failure.
Chronic progressive external ophthalmoplegia (CPEO) is
among the most commonly observed features, reported in
nearly two-thirds of patients with mitochondrial myop-
athy. Molecular diagnosis is often pursued but the* Correspondence: pbonnen@bcm.edu
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reproduction in any medium, provided the ormajority of these complex patients remain without a
DNA-based diagnosis.
Pediatric-onset mitochondrial diseases are a diverse
group and estimated to occur with an incidence of
1/5,000 [1]. Most cases (85–90%) are likely due to
nuclear-encoded mutations, and autosomal recessive
transmission is observed most commonly [1,2]. Despite
their common occurrence, little is known about the
molecular genetic basis of mitochondrial disorders.
We applied whole exome sequencing to identify patho-
genic mutations in a patient with suspected pediatric-onset
mitochondrial disease. The patient’s clinical presentation
included classic hallmarks of mitochondrial disease: con-
genital cataracts, CPEO, early onset symmetric bilateral
ptosis, progressive constitutional weakness, and ataxia.
Exome sequencing revealed mutations in multiple genesl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Informed consent was obtained from the subject and his
parents for research and publication of clinical details
according to a protocol approved by the Institutional
Review Board for Baylor College of Medicine and Affiliated
Hospitals. Genomic DNA was extracted from peripheral
leukocytes and saliva according to standard protocols.
Sequencing
We performed sequencing with a custom capture design
called ‘VCROME’ developed at the BCM Human Gen-
ome Sequencing Center that enriches for approximately
20,000 genes comprising a total of 45 Mb of captured
genomic sequence [3]. Coding exons in the Vega, Con-
sensus Coding Sequence (CCDS) exons, and RefSeq an-
notation sets were targeted in addition to miRNAs from
miRBase (release 10). In addition, 8 MB of untranslated
regions (UTR) were enriched in this capture design.
Probe pools were manufactured by Roche NimbleGen
(Madison, WI). Samples were sequenced in a paired-end
strategy on an Illumina HiSeq 2000 instrument with one
lane per sample.
Targeted re-sequencing of both SETX and OCRL
was completed for the propositus and each parent
with primers SETXF1 TGACATTTCCTGTCAATGC
CTC, SETXR1 GAATAACTCCCGGTGAGCCC, OCRLF1
GGACAGGAGGTAGCCAGAGAT, and OCRLR1 CGG
CTTACTTTCTTATACTTGGC. The region was PCR-
amplified and sequenced by di-deoxy terminator se-
quencing on an ABI 3730XL. All chromatograms were
inspected manually, and genotype calls were based on
bi-directional sequence reads with phred quality score > 20.
Sequence data analysis and bioinformatics
Sequence data were aligned with BWA software to hu-
man reference sequence HG19 [4]. Duplicate reads were
removed with the Picard program. Recalibration and re-
alignment of the data were accomplished with GATK
[5,6]. Single nucleotide variants (SNVs) were called with
Samtools [7]. Small insertions and deletions (InDels)
were determined by GATK. Quality control filtering of
variants was based on coverage, strand bias, mapping
quality, and base quality. Annotation of variants was
conducted with internally developed Perl scripts. Predic-
tion for potential functional consequences of variants
was conducted with SIFT [8], PolyPhen2 [9], and PhyloP
[10] using dbNSFP [11] and its scoring system which
scales each of these metrics from 0 to 1 with 1 being
most damaging. The evolutionary conservation of mis-
sense mutations was also determined by GenomicEvolutionary Rate Profiling (GERP) which approximates
evolutionary constraint at a locus by maximum likelihood
estimation [12,13]. The GERP++ score reported here is
based on the alignment of 35 mammalian species and the
maximum GERP score for this analysis is 6.18.
Clinical description
The patient is a 33-year-old male, born to a then 20-year
old mother following an uncomplicated pregnancy. His
parents are first cousins of Persian descent. Infantile
cataracts were noted at 3 months of age and the lenses
removed shortly thereafter. Hypospadias (without crypt-
orchidism) was surgically repaired in infancy. His motor
development was thought to be normal during early
childhood, but CPEO, ptosis, and progressive distal
muscle weakness developed in early adolescence, and
ataxia and tremors became apparent as a young adult. A
muscle biopsy was performed when the patient was an
adolescent, but the results of the evaluation are not
available; however, the family was told the results were
inconclusive. Surgical correction of bilateral ptosis was
not successful. Because of progressive ataxia, a magnetic
resonance imaging (MRI) of the brain was performed
when the patient was 25 years old and it demonstrated
cerebellar atrophy.
The family history was notable for a younger sibling
who died at 8 months of age of congenital heart disease.
His mother has cerulean cataracts that do not interfere
with her vision and were identified when she was in her
20’s. The maternal grandmother had cataract surgery
when she was in her 50s. The patient’s mother had 3
siblings including a brother who underwent cataract
surgery at 4 years of age and who died at 39 years of age
from an accident. A second brother has no history of
cataracts, while a sister also has cataracts. One of the
sister’s two children has cataracts that have not required
surgery. In the father’s family there is no history of
cataracts.
The physical examination of the patient was notable
for bilateral ptosis, complete CPEO with a small angle
esotropia and a normal retinal exam, neck weakness, ex-
tremity weakness that was more prominent in the lower
extremities, upper extremity tremors, and symmetrically
markedly reduced reflexes.
Relevant clinical biochemical and molecular diagnostic
testing performed at 30 years of age included plasma thy-
midine level, urine organic acids analysis, carbohydrate-
deficient transferrin analysis, a complete metabolic panel,
and TSH, all of which were normal. The blood lactate was
increased at 2.6 mM (normal range 0.2-2.0 mM), as was
creatine kinase at 279 U/L (normal range 55–170 U/L).
Genetic diagnostic testing included whole mitochon-
drial genome sequencing which detected one homo-
plasmic rare variant (m.3110C > T) in the 16S rRNA
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a polymorphism (http://www.mitomap.org/MITOMAP/).
Additional diagnostic sequencing of three nuclear genes
known to cause CPEO; POLG, C10ORF2, and ANT1, also
found no deleterious mutations, and OPA1 sequencing
was also normal.
Results
Exome sequencing of the proband resulted in 127X aver-
age coverage of targeted regions and 98% of targeted
bases having at least 10 reads. Variant analysis revealed
17,328 total coding single nucleotide variants (SNVs)
with a transition/transversion ratio of 3.3, and 188 total
small insertions and deletions (InDels) (Table 1). Due to
the patient’s clinical diagnosis of suspected pediatric-
onset mitochondrial disease, exome sequence results
were analyzed with an assumed recessive genetic model.
Fifteen (15) homozygous or hemizygous SNVs and 4
homozygous InDels were not reported in dbSNP137.
One of the SNVs is predicted to affect splicing. Four of
the SNVs were non-synonymous missense mutations; of
these two were predicted to damage protein function
due to high conservation across species (Table 2).
Analysis of results of exome sequencing showed that
the patient is homozygous for a splice site mutation in
senataxin (SETX). This mutation, SETX c.5375-1G > A
(GenBank Accession Number: NM_015046.5), is in
the −1 position of exon 10 of the SETX transcript. SETX
has a total of 24 exons encoding a protein of 2677 amino
acids long and contains at its C terminus a seven-motif
domain that places it in the superfamily 1 of helicases.
Recessive mutations in SETX cause Spinocerebellar Ataxia,
Autosomal Recessive 1 (SCAR1, OMIM 606002). Patients
typically develop juvenile-onset progressive ataxia, and
some but not all patients exhibit oculomotor apraxia,
hence the condition has also been termed ataxia with
oculomotor apraxia type 2 (AOA2). Other features
include increases in serum alpha-fetoprotein and creatine
kinase. The clinical phenotype previously reported for
SCAR1 parallels the ataxia, tremor, cerebellar atrophy,
and hyporeflexia observed in the patient described here,
thus, the homozygous SETX splice site mutation likely
accounts for the patient’s ataxia. Heterozygous missenseTable 1 Summary of coding variants identified through exom
A
ALL
Ti/Tv Total Het Hom Total
3.0 17328 10277 7051 17048
B
ALL KNOWN NOVEL INSERTION DELETIO
427 342 85 228 199
A: Single nucleotide variants and B: small insertions and deletions. Variants are listesubstitutions in SETX can give rise to dominant juvenile
amyotrophic lateral sclerosis (ALS4, OMIM 602433).
The patient also has several clinical features that have
not been reported to occur in SCAR1. In particular, the
patient does not have ocular apraxia but rather CPEO,
ptosis, and a history of bilateral congenital cataracts, fea-
tures not reported in a recent survey of 90 mutation
positive cases of SCAR1/AOA2 [14]. Given this clinical
picture, the possibility that more than one gene locus
gave rise to the patient’s phenotype was entertained, and
the identified variants were re-analyzed with both reces-
sive and dominant genetic models. Further review of the
list of genes harboring variants not found in public data-
bases and predicted to be damaging to protein function
failed to identify any genes that have been annotated as
part of the mitochondrial proteome, but did reveal an
additional missense variant in the known disease gene,
OCRL. Mutations in OCRL cause Lowe Syndrome as
well as Dent2 disease. The oculocerebrorenal syndrome
of Lowe includes variable involvement of the eyes, brain,
and kidneys that could possibly explain the patient’s
historical congenital cataracts. The missense variant,
OCRL c.850G > A; p.E284K (GenBank Accession
Number: NM_000276.3), was identified in exon 10. Most
persons with Lowe Syndrome have mutations in exons
10–23 and many of these are missense [15]. Two differ-
ent tests for evolutionary conservation, GERP and
PhyloP, both showed that this base position is highly
constrained. The GERP test for evolutionary sequence
conservation yielded a score of 5.44, which is the
maximum or most constrained score possible (Table 2).
PhyloP analysis also showed significant evidence for
conservation (score = 1). Software programs that predict
whether a missense mutation is damaging to protein
function scored this variant with the most damaging
score (Sift = 1, PolyPhen2 = 1). Additionally, this OCRL
variant is not present in either dbSNP or HGMD.
There is substantial bioinformatics support that this
mutation damages protein function and therefore would
manifest as Lowe Syndrome in this male, however, we
were unable to complete a full clinical assessment for
Lowe Syndrome in the patient because the patient was
not available for further clinical investigations. Likewise,e sequencing
KNOWN NOVEL
Het Hom Total Het Hom
10012 7036 280 265 15
N HET HOM NOVEL HOM
239 188 4
d as novel if not present in dbSNP137.
Table 2 Summary of novel non-synonymous coding homozygous variants in patient





GERP PhyloP SIFT Polyphen2 OMIM disorders
9 135176191 C T SETX Splice Splice - 4.88 - - - Ataxia-ocular apraxia-2, 606002 (3); Amyotrophic lateral
sclerosis4, juvenile, 602433 (3)
X 128695181 G A OCRL Exon_CDS Missense E284K 5.44 1.00 1.00 0.99 Lowe syndrome, 309000 (3); Dent disease 2, 300555 (3)
4 86863251 C T ARHGAP24 Exon_CDS Missense R47C 5.11 1.00 0.90 0.94 -
X 3021820 G A ARSF Exon_CDS Missense G374S 3.43 0.99 0.86 0.18 -
X 153524232 G A TKTL1 Exon_CDS Missense R7K 0.12 0.22 0.80 0.19 -
4 88536013 TAGCAGTGACAGCAGCAAC T DSPP Exon_CDS Deletion - 0.409 - - Dentinogenesis imperfecta, Shields type II/III, 125490/
125500 (3); Deafness,autosomal dominant 36, with
dentinogenesis, 605594 (3);
10 33136818 TAA T C10orf68 Exon_CDS Deletion - −0.964 - - - -
15 42302337 CA C PLA2G4E Exon_CDS Deletion - 1.58 - - - -
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to confirm directly if the SETX c.5375-1G > A results in
the loss of exon 10 or otherwise affects this protein.
DNA samples from each parent were sequenced. Each
was heterozygous for the SETX splice site mutation, and
the mother was found to be a carrier of the OCRL vari-
ant. The patient’s mother did not display the characteris-
tic cortical flecks in the lens typical of Lowe Syndrome
carriers, but instead she has bilateral cerulean cataracts
that were first discovered when she was in her 20’s. The
mother’s pedigree shows three other family members
with cataracts, one who had an early age of onset neces-
sitating surgery (Figure 1). The possibility of an inde-
pendent locus segregating in this family that confers
autosomal dominant cataract was evaluated. We queried
the patient’s exome variants present in genes known to
cause all inherited forms of cataract, reviewed in Huang
et al. 2010 [16]. No variants that were predicted to dam-
age protein function were identified in any known cata-
ract gene. This includes four known cerulean cataract
genes: MAF, CRYG, CRYBB2, and GJA3. AscertainmentFigure 1 Pedigree of patient with ataxia and congenital cataracts. Fou
cataracts. Genotypes for the SETX mutation chr9:135,176,191, C > T and the
and his parents. Several members of the maternal lineage were noted to hof CRYG and CRYBB2 coding region was 100% in the
exome dataset. However, part of the first exon of MAF
and the last exon of GJA3 are both repeat rich and as a
result was not targeted by exome capture. Attempts to
sequence these gene regions by Sanger sequencing were
unsuccessful.
Discussion
We describe a patient with a complex clinical presenta-
tion including congenital cataracts, CPEO, ptosis, pro-
gressive systemic neuromuscular weakness, cerebellar
atrophy, ataxia, and tremors, and the results of sequen-
cing his exome. Exome sequencing revealed potentially
pathogenic variants in two genes: SETX and OCRL, each
of which may contribute to this complex phenotype.
Recently, senataxin was found to harbor RNA/DNA
helicase activity important in mRNA transcription, with
an ability to unwind RNA/DNA hybrids formed behind
the elongating RNA Polymerase II between the nascent
RNA transcript and single-stranded DNA template.
This activity is likely important in the termination ofr generations of the family of a proband with ataxia and congenital
OCRL mutation is chrX:128695181, G > A are shown for the proband
ave early onset cataracts.
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studies in yeast point to a similar 3’ processing function
in noncoding RNAs [18], suggesting that perturbations
in global gene expression may underlie the pleiotropic
features of the disease.
This study represents the challenges in diagnosing pa-
tients with complex clinical phenotypes and the interpret-
ation of exome sequence data, a technology that is moving
rapidly into clinical diagnostics. This patient’s initial
diagnosis of mitochondrial disease was suggested by his
findings and offered without the benefit of genome-wide
sequence data. Exome sequencing revealed that his com-
plex phenotype reflects a complex genetic etiology in
which no single gene explained the complete clinical pres-
entation. The mutation found in SETX partially explains
his clinical diagnosis, while the pathogenicity of the OCRL
missense variant remains undetermined. There is strong
bioinformatics support for pathogenicity, however, the pa-
tient was not available for further clinical investigations
and the patient’s mother did not exhibit the classic ocular
phenotype of heterozygotes of Lowe Syndrome mutations.
We considered the possibility of an independent locus
causing the congenital cataracts in this patient. Exome
data for genes known to cause dominantly inherited
cataracts were queried and no variants with predicted
pathogenicity were found. In summary, exome sequencing
improves the diagnostic reservoir, and some patients may
require further clinical and/or functional studies to
achieve a complete diagnosis.Conclusions
Exome sequencing studies identified mutations in mul-
tiple independent loci in a patient with typical features
of mitochondrial disease including infantile cataracts,
CPEO, ptosis, progressive distal muscle weakness, and
ataxia who carried a diagnosis of mitochondrial disease
for over a decade. Sequencing revealed a homozygous
splice site mutation in SETX, which is known to cause
Spinocerebellar Ataxia, Autosomal Recessive 1 (SCAR1),
as well as a missense mutation in a highly conserved
position of the OCRL gene, which causes Lowe
Syndrome and Dent Disease 2. This patient’s complex
phenotype reflects a complex genetic etiology in which
no single gene explained the complete clinical presenta-
tion. These genetic studies reveal that this patient does
not have mitochondrial disease but rather a genocopy
caused by more than one mutant locus. This study dem-
onstrates the benefit of exome sequencing in providing
molecular diagnosis to individuals with complex clinical
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